CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-20 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −1,252 | $25.08 | $31K | 21,110 |
| 2022-02-20 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −3,824 | 7,649 | ||
| 2022-02-20 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise | +5,354 | 228,355 | ||
| 2022-02-20 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Shares withheld for taxes | −2,368 | $25.08 | $59K | 225,987 |
| 2022-02-20 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −5,354 | 10,708 | ||
| 2022-02-20 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +4,589 | 79,153 | ||
| 2022-02-20 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −1,335 | $25.08 | $33K | 77,818 |
| 2022-02-20 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −4,589 | 9,178 | ||
| 2022-02-20 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Option exercise | +7,036 | 89,831 | ||
| 2022-02-20 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −2,061 | $25.08 | $52K | 87,770 |
| 2022-02-20 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −7,036 | 14,073 | ||
| 2022-02-20 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise | +4,589 | 52,946 | ||
| 2022-02-20 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −1,348 | $25.08 | $34K | 51,598 |
| 2022-02-20 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise · Restricted Stock Unit Award | −4,589 | 9,178 | ||
| 2022-02-18 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | −2,306 | $25.17 | $58K | 9,496 |
| 2022-02-18 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +139,554 | 139,554 | ||
| 2022-02-18 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Grant or award · Restricted Stock Unit Award | +34,889 | 34,889 | ||
| 2022-02-18 | POPS RICHARD F Director and CEO, Alkermes plc | Grant or award · Employee Stock Option (Right to Buy) | +299,044 | 299,044 | ||
| 2022-02-18 | Nichols Christian Todd SVP, Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +99,682 | 99,682 | ||
| 2022-02-18 | Nichols Christian Todd SVP, Chief Commercial Officer | Grant or award · Restricted Stock Unit Award | +24,921 | 24,921 |
Page 55 of 60 · 1,194 trades